Table 2. Prevalence of Mycoplasma genitalium^a and of Neisseria gonorrhoeae and Chlamydia trachomatis infections^b by anatomical site, n=716.

Type of sample (n)	Positive samples	Adjusted prevalencec
	n	%	95% CI
Pharyngeal swab (n=688)
M. genitalium	2	0.2	0.1–0.9
N. gonorrhoeae	15	1.5	0.8–2.6
C. trachomatis	7	0.8	0.2–3.0
Urethral swab (n=687)
M. genitalium	23	2.2	1.2–4.0
N. gonorrhoeae	0	0.0	N/A
C. trachomatis	5	1.9	0.4–8.6
Rectal swab (n=688)
M. genitalium	41	4.0	2.6–6.0
N. gonorrhoeae	12	1.4	0.6–3.3
C. trachomatis	22	2.6	1.2–5.5
Rectal or urethral swab (n=716)
M. genitalium	61	5.7	4.0–8.1

Abbreviations: CI, confidence interval; C. trachomatis, Chlamydia trachomatis; M. genitalium, Mycoplasma genitalium; N. gonorrhoeae, Neisseria gonorrhoeae; N/A, not available

^a Using Allplex^TM CT/NG/MG/TV Assay

^b Using the cobas^® 4800 system

^c Adjusted for respondent-driven sampling recruitment and censoring